TIP30 interacts with an estrogen receptor α-interacting coactivator CIA and regulates c-myc transcription

被引:68
作者
Jiang, C
Ito, M
Piening, V
Bruck, K
Roeder, RG
Xiao, H
机构
[1] Univ Nebraska, Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA
[3] Kobe Univ, Sch Med, Dept Med, Div Hematol Oncol,Chuo Ku, Kobe, Hyogo 6500017, Japan
[4] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA
关键词
D O I
10.1074/jbc.M401809200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deregulation of c-myc expression is implicated in the pathogenesis of many neoplasias. Estrogen receptor alpha (ERalpha) can increase the rate of c-myc transcription through the recruitment of a variety of cofactors to the promoter, yet the precise roles of these cofactors in transcription and tumorigenesis are largely unknown. We show here that a putative tumor suppressor TIP30, also called CC3 or Htatip2, interacts with an ERalpha-interacting coactivator CIA. Using chromatin immunoprecipitation assays, we demonstrate that TIP30 and CIA are distinct cofactors that are dynamically associated with the promoter and downstream regions of the c-myc gene in response to estrogen. Both TIP30 and CIA are recruited to the c-myc gene promoter by liganded ERalpha in the second transcription cycle. TIP30 overexpression represses ERalpha-mediated c-myc transcription, whereas TIP30 deficiency enhances c-myc transcription in both the absence and presence of estrogen. Ectopic CIA cooperates with TIP30 to repress ERalpha-mediated c-myc transcription. Moreover, virgin TIP30 knockout mice exhibit increased c-myc expression in mammary glands. Together, these results reveal an important role for TIP30 in the regulation of ERalpha-mediated c-myc transcription and suggest a mechanism for tumorigenesis promoted by TIP30 deficiency.
引用
收藏
页码:27781 / 27789
页数:9
相关论文
共 43 条
[1]   THE HUMAN C-MYC-ONCOGENE - STRUCTURAL CONSEQUENCES OF TRANSLOCATION INTO THE IGH LOCUS IN BURKITT-LYMPHOMA [J].
BATTEY, J ;
MOULDING, C ;
TAUB, R ;
MURPHY, W ;
STEWART, T ;
POTTER, H ;
LENOIR, G ;
LEDER, P .
CELL, 1983, 34 (03) :779-787
[2]   Reciprocal recruitment of DRIP/mediator and p160 coactivator complexes in vivo by estrogen receptor [J].
Burakov, D ;
Crofts, LA ;
Chang, CPB ;
Freedman, LP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) :14359-14362
[3]   The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting [J].
Cardiff, RD ;
Anver, MR ;
Gusterson, BA ;
Hennighausen, L ;
Jensen, RA ;
Merino, MJ ;
Rehm, S ;
Russo, J ;
Tavassoli, FA ;
Wakefield, LM ;
Ward, JM ;
Green, JE .
ONCOGENE, 2000, 19 (08) :968-988
[4]   Estrogen receptor null mice: What have we learned and where will they lead us? [J].
Couse, JF ;
Korach, KS .
ENDOCRINE REVIEWS, 1999, 20 (03) :358-417
[5]  
Couse JF, 1999, ANN ENDOCRINOL-PARIS, V60, P143
[6]  
Cunha GR, 2000, ADV EXP MED BIOL, V480, P93
[7]   c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations [J].
D'Cruz, CM ;
Gunther, EJ ;
Boxer, RB ;
Hartman, JL ;
Sintasath, L ;
Moody, SE ;
Cox, JD ;
Ha, SI ;
Belka, GK ;
Golant, A ;
Cardiff, RD ;
Chodosh, LA .
NATURE MEDICINE, 2001, 7 (02) :235-239
[8]   ACCURATE TRANSCRIPTION INITIATION BY RNA POLYMERASE-II IN A SOLUBLE EXTRACT FROM ISOLATED MAMMALIAN NUCLEI [J].
DIGNAM, JD ;
LEBOVITZ, RM ;
ROEDER, RG .
NUCLEIC ACIDS RESEARCH, 1983, 11 (05) :1475-1489
[9]  
DUBIK D, 1992, ONCOGENE, V7, P1587
[10]   The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II [J].
Ferdous, A ;
Gonzalez, F ;
Sun, LP ;
Kodadek, T ;
Johnston, SA .
MOLECULAR CELL, 2001, 7 (05) :981-991